Kairos Pharma (KAPA) Q4 2024 Earnings

Nov 14Confirmed
Q1 1
Q4 2024
-0.05
-0.04
-0.03
-0.02

Details

Expected EPS
-0.02
Actual EPS
-0.05
Surprise EPS
-0.03
Surprise Percent
-150%

Description

⁨Kairos Pharma⁩ (⁦KAPA⁩) has reported earnings of ⁦-0.05⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts